Literature DB >> 7837077

Collagen types in human posterior capsule opacification.

T Ishibashi1, T Hatae, H Inomata.   

Abstract

The fibrous type of human posterior capsule opacification was examined by electron microscopy and immunoelectron microscopy to determine which types of collagen were present. The opacification consisted of lens epithelial cells and a large amount of extracellular matrix. The extracellular matrix comprised collagen fibrils and basal lamina-like material. Immunoelectron microscopy revealed that collagen types I, III, and IV were present. Types I and III were localized to the collagen fibrils. Type IV was present in the basal lamina of the lens epithelial cells and in the basal lamina-like material of the extracellular matrix.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7837077     DOI: 10.1016/s0886-3350(13)80655-4

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  15 in total

1.  Consistent pattern in positional instability of polyfocal full-optics accommodative IOL.

Authors:  Yu Cheol Kim; Kyung Tae Kang; Youngdo Yeo; Ki-San Kim; Frank S Siringo
Journal:  Int Ophthalmol       Date:  2016-12-05       Impact factor: 2.031

2.  Moderate oxidative stress promotes epithelial-mesenchymal transition in the lens epithelial cells via the TGF-β/Smad and Wnt/β-catenin pathways.

Authors:  Xi Chen; Hong Yan; Ying Chen; Guo Li; Yue Bin; Xiyuan Zhou
Journal:  Mol Cell Biochem       Date:  2021-01-08       Impact factor: 3.396

3.  Reduced Glutathione Level Promotes Epithelial-Mesenchymal Transition in Lens Epithelial Cells via a Wnt/β-Catenin-Mediated Pathway: Relevance for Cataract Therapy.

Authors:  Zongbo Wei; Jane Caty; Jeremy Whitson; Amy D Zhang; Ramkumar Srinivasagan; Terrance J Kavanagh; Hong Yan; Xingjun Fan
Journal:  Am J Pathol       Date:  2017-08-19       Impact factor: 4.307

4.  Deposition of extracellular matrix on intraocular lenses in rabbits: an immunohistochemical and transmission electron microscopic study.

Authors:  S Saika; S Tanaka; S Ohmi; A Minamide; Y Ohnishi; A Yamanaka; A Ooshima; M Kimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-04       Impact factor: 3.117

5.  Effect of delivery of MMP inhibitors from PDMS as a model IOL material on PCO markers.

Authors:  Diana Morarescu; Judy A West-Mays; Heather D Sheardown
Journal:  Biomaterials       Date:  2009-12-22       Impact factor: 12.479

6.  Immunocytochemical features of lens after cataract tissue--signalling molecules (growth factors, cytokines, other signalling molecules), cytoskeleton proteins, cellular and extracellular matrix proteins.

Authors:  T Shigemitsu; K Ishiguro; Y Shimizu; M Horiguchi; M Kasahara; S Arakaki
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

7.  TGFbeta induces morphological and molecular changes similar to human anterior subcapsular cataract.

Authors:  Frank J Lovicu; Mark W Schulz; Angela M Hales; Lisa N Vincent; Paul A Overbeek; Coral G Chamberlain; John W McAvoy
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

8.  Collagen synthesis in lens epithelial cells on capsules containing intraocular lens implants in rabbits: immunolocalization of prolyl 4-hydroxylase.

Authors:  S Saika; S Ohmi; A Ooshima; M Kimura; K Ohkawa; Y Okada; S Tanaka; Y Ohnishi; A Yamanaka
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-12       Impact factor: 3.117

9.  Adherence and viability of porcine lens epithelial cells on three different IOL materials in vitro.

Authors:  Yvonne Hesse; Jürgen Kampmeier; Gerhard K Lang; Alicia Baldysiak-Figiel; Gabriele E Lang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-08-23       Impact factor: 3.117

10.  Recombinant tissue plasminogen activator in cases with fibrin formation after cataract surgery: a prospective randomised multicentre study.

Authors:  A Heiligenhaus; B Steinmetz; R Lapuente; P Krallmann; C Althaus; W K Steinkamp; B Dick
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.